Answers are grounded in this paper and cite their sources.
Purpose To evaluate the comparative effectiveness and safety of MRI-based and image-guided brachytherapy in patients with locally advanced cervical cancer (LACC), with analyses stratified by historical conventional or non-volumetric brachytherapy and contemporary CT-guided brachytherapy comparators. Materials and methods PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to May 12, 2026, with an updated search conducted on October 4, 2026. Retrospective comparative cohort studies comparing MRI-based or other image-guided brachytherapy strategies with historical conventional or non-volumetric brachytherapy or contemporary CT-guided brachytherapy were included. Time-to-event outcomes were synthesized using hazard ratios (HRs), and dichotomous outcomes were summarized using risk ratios (RRs). The certainty of evidence was assessed using the GRADE framework. Results Twelve retrospective comparative cohort studies involving 2,129 patients were included. MRI-based/image-guided brachytherapy was associated with improved overall survival (OS) compared with historical conventional or non-volumetric brachytherapy (HR = 0.50, 95% CI 0.36–0.71), whereas no statistically significant OS difference was observed versus contemporary CT-guided brachytherapy (HR = 0.59, 95% CI 0.27–1.29). Similar patterns were observed for PFS/DFS-related outcomes, with a favorable association against historical comparators (HR = 0.31, 95% CI 0.20–0.50) but no statistically significant difference versus contemporary CT-guided brachytherapy (HR = 0.81, 95% CI 0.43–1.51). Pelvic disease control was improved compared with historical conventional or non-volumetric brachytherapy (HR = 0.19, 95% CI 0.09–0.42). No statistically significant difference was observed in late grade ≥3 gastrointestinal toxicity between MRI-based or MRI-assisted and contemporary CT-guided brachytherapy (RR = 1.26, 95% CI 0.72–2.22). Conclusion MRI-based/image-guided brachytherapy was associated with improved survival and disease control compared with historical conventional or non-volumetric brachytherapy. However, current evidence does not demonstrate a clear incremental clinical benefit of MRI guidance over contemporary CT-guided brachytherapy. Given the retrospective design, limited direct MRI-versus-CT evidence, and potential confounding by treatment era and evolving brachytherapy techniques, these findings should be interpreted cautiously. Further prospective comparative studies are needed to clarify the incremental value of MRI-guided adaptive brachytherapy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: